Kiora Pharmaceuticals, Inc.

DB:7EY0 Stock Report

Market Cap: €13.9m

Kiora Pharmaceuticals Management

Management criteria checks 3/4

Kiora Pharmaceuticals' CEO is Brian Strem, appointed in Jul 2021, has a tenure of 2.83 years. total yearly compensation is $802.27K, comprised of 51.9% salary and 48.1% bonuses, including company stock and options. directly owns 0.39% of the company’s shares, worth €54.56K. The average tenure of the management team and the board of directors is 2.6 years and 3.1 years respectively.

Key information

Brian Strem

Chief executive officer

US$802.3k

Total compensation

CEO salary percentage51.9%
CEO tenure2.8yrs
CEO ownership0.4%
Management average tenure2.6yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Brian Strem's remuneration changed compared to Kiora Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$2m

Dec 31 2023US$802kUS$416k

-US$13m

Sep 30 2023n/an/a

-US$13m

Jun 30 2023n/an/a

-US$12m

Mar 31 2023n/an/a

-US$12m

Dec 31 2022US$714kUS$400k

-US$14m

Sep 30 2022n/an/a

-US$17m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$659kUS$169k

-US$14m

Compensation vs Market: Brian's total compensation ($USD802.27K) is above average for companies of similar size in the German market ($USD385.89K).

Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.


CEO

Brian Strem (43 yo)

2.8yrs

Tenure

US$802,274

Compensation

Dr. Brian M. Strem, Ph D., is Co-Founder and Director at Okogen, Inc. He served as Principal Financial and Accounting Officer of Kiora Pharmaceuticals, Inc. since June 16, 2022. He serves as President, Dir...


Leadership Team

NamePositionTenureCompensationOwnership
Brian Strem
President2.8yrsUS$802.27k0.39%
$ 54.5k
Melissa Tosca
Executive Vice President of Finance1.7yrsUS$387.48k0.13%
$ 18.4k
Eric Daniels
Chief Development Officer2.6yrsUS$652.31k0.34%
$ 46.6k
Stefan Sperl
Executive Vice President of CMC & Operationsno datano datano data

2.6yrs

Average Tenure

43yo

Average Age

Experienced Management: 7EY0's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Brian Strem
President2.8yrsUS$802.27k0.39%
$ 54.5k
Daniel Durrie
Member of Scientific Advisory Board7.2yrsno datano data
Praveen Tyle
Independent Chairman of the Board15.9yrsUS$98.25k0.00040%
$ 55.5
Paul Karpecki
Member of Scientific Advisory Board6.6yrsno datano data
Aron Shapiro
Director3.1yrsUS$70.12k0%
$ 0
Kenneth Gayron
Independent Director3.1yrsUS$92.62k0%
$ 0
Victor Perez
Member of Scientific Advisory Board6.3yrsno datano data
David Hollander
Independent Director2.4yrsUS$77.62k0%
$ 0
Erin Parsons
Non-Employee Independent Director2.3yrsUS$84.50k0%
$ 0
Allen Ho
Member of Scientific Advisory Boardno datano datano data
Christine Kay
Member of Scientific Advisory Boardno datano datano data
Francis Mah
Member of Scientific Advisory Boardno datano datano data

3.1yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 7EY0's board of directors are considered experienced (3.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.